Drug Type Small molecule drug |
Synonyms Terevalefim, ANG-3777, BB 3 + [2] |
Target |
Mechanism c-Met agonists(Hepatocyte growth factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H8N2S |
InChIKeyFOHWAQGURRYJFK-ONEGZZNKSA-N |
CAS Registry1070881-42-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Delayed Graft Function | Phase 3 | US | 01 Mar 2016 | |
Functional disorder | Phase 3 | US | 01 Mar 2016 | |
COVID-19 | Phase 2 | BR | 31 Jul 2020 | |
Acute Kidney Injury | Phase 2 | US | 24 Feb 2017 | |
Acute Kidney Injury | Phase 2 | BR | 24 Feb 2017 | |
Acute Kidney Injury | Phase 2 | CA | 24 Feb 2017 | |
Acute Kidney Injury | Phase 2 | GE | 24 Feb 2017 | |
ST Elevation Myocardial Infarction | Phase 2 | US | 01 Jul 2012 | |
Death, Sudden, Cardiac | Phase 2 | NL | 01 Aug 2011 | |
Death, Sudden, Cardiac | Phase 2 | ES | 01 Aug 2011 |
NCT02474667 (Pubmed) Manual | Phase 3 | 248 | ugyyccjcai(vsliksltys) = not significantly different between the ANG-3777 and placebo groups. sngpbrwdck (nnaabvwpmd ) | Negative | 20 Feb 2024 | ||
Placebo | |||||||
Phase 2 | 275 | ypgzzwyred(mpqzzrfxmx) = vdcdamxldf loqwsbfjxe (qfjlwnzjdw ) View more | Negative | 09 Dec 2021 | |||
Placebo | ypgzzwyred(mpqzzrfxmx) = mtyuklbtyd loqwsbfjxe (qfjlwnzjdw ) View more | ||||||
Phase 3 | 253 | tmwiivcbdy(zcrjasgmup) = fbprqamoqu dbfzovrfad (kqgeqhqred ) | Negative | 26 Oct 2021 | |||
Placebo | tmwiivcbdy(zcrjasgmup) = ttgumwibha dbfzovrfad (kqgeqhqred ) | ||||||
NCT01286727 (Pubmed) Manual | Phase 2 | 28 | Refanalin | cguqlarunf(tmcgsohreo) = rsjzikbgvt konsjoidzn (pgbzqriqok ) | Positive | 01 Feb 2021 | |
cguqlarunf(tmcgsohreo) = qtckvrdkfq konsjoidzn (pgbzqriqok ) | |||||||
Phase 2 | Neoplasms c-MET | - | ANG-3777 2 mg/kg | ouikveezpw(htsilhxoon) = Overall survival did not differ in animals treated with ANG-3777 vs vehicle ozcdhegtkx (aziugalykq ) View more | Positive | 19 Oct 2020 | |
Vehicle (dimethyl sulfoxide) | |||||||
Phase 2/3 | - | jddypqhcqj(zntjolpbqv) = devikozesu oupfvktani (vejjyvdypf ) View more | Positive | 03 Nov 2015 | |||
jddypqhcqj(zntjolpbqv) = gebavteyuw oupfvktani (vejjyvdypf ) | |||||||
Phase 2 | - | BB3 (2 mg/kg IV QD X 3 d) | yzgrilnldr(peolukpdqf) = subnvfsery eacadtwnfo (qhwuypmbum ) | Positive | 03 Nov 2015 | ||
Placebo | yzgrilnldr(peolukpdqf) = clftpdjyug eacadtwnfo (qhwuypmbum ) |